Barriers to effective TRAIL-targeted therapy of malignancy

被引：83

作者：

Dyer, Martin J. S. ^{[1
]}

MacFarlane, Marion ^{[1
]}

Cohen, Gerald M. ^{[1
]}

机构：

[1] MRC, Toxicol Unit, Leicester, Leics, England

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 28期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1200/JCO.2007.13.1011

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4505 / 4506

页数：3

共 10 条

[1] On the TRAIL toward death receptor-based cancer therapeutics [J].

Gajewski, Thomas F. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (11) :1305-1307

[2] Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignancies [J].

Inoue, S ;

MacFarlane, M ;

Harper, N ;

Wheat, LMC ;

Dyer, MJS ;

Cohen, GM .

CELL DEATH AND DIFFERENTIATION, 2004, 11 (Suppl 2) :S193-S206

[3] Inhibition of histone deacetylase class I but not class II is critical for the sensitization of leukemic cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis [J].

Inoue, Satoshi ;

Mai, Antonello ;

Dyer, Martin J. S. ;

Cohen, Gerald M. .

CANCER RESEARCH, 2006, 66 (13) :6785-6792

[4]

KOSCHNY R, J MOL MED

[5] Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis [J].

Koschny, Ronald ;

Holland, Heidrun ;

Sykora, Jaromir ;

Haas, Tobias L. ;

Sprick, Martin R. ;

Ganten, Tom M. ;

Krupp, Wolfgang ;

Bauer, Manfred ;

Ahnert, Peter ;

Meixensberger, Juergen ;

Walczak, Henning .

CLINICAL CANCER RESEARCH, 2007, 13 (11) :3403-3412

[6] TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies [J].

MacFarlane, M ;

Kohlhaas, SL ;

Sutcliffe, MJ ;

Dyer, MJS ;

Cohen, GM .

CANCER RESEARCH, 2005, 65 (24) :11265-11270

[7] Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1 [J].

MacFarlane, M ;

Inoue, S ;

Kohlhaas, SL ;

Majid, A ;

Harper, N ;

Kennedy, DBJ ;

Dyer, MJS ;

Cohen, GM .

CELL DEATH AND DIFFERENTIATION, 2005, 12 (07) :773-782

[8] Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia [J].

MacFarlane, M ;

Harper, N ;

Snowden, RT ;

Dyer, MJS ;

Barnett, GA ;

Pringle, JH ;

Cohen, GM .

ONCOGENE, 2002, 21 (44) :6809-6818

[9] mTOR controls FLIPs translation and TRAIL sensitivity in glioblastoma multiforme cells [J].

Panner, A ;

James, CD ;

Berger, MS ;

Pieper, RO .

MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (20) :8809-8823

[10]

Tolcher AW, 2007, J CLIN ONCOL, V25, P1390, DOI 10.1200/JCO.2006.08.8898

← 1 →